Establishment Labs Holdings Inc.

As of June 30, 2026, Establishment Labs Holdings, Inc. carries a market capitalization of 2.24B, placing it among publicly traded companies globally. Its enterprise value stands at 2.41B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Establishment Labs Holdings, Inc.'s next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Establishment Labs Holdings, Inc. has 29.79M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 10.45, and the price-to-book ratio stands at 118.56.

These figures are as of June 30, 2026. The EV/Sales ratio of 11.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.41B versus a market cap of 2.24B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Establishment Labs Holdings, Inc. maintains a current ratio of 3.84, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,220.32, indicating moderate leverage, while an interest coverage ratio of -0.29 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Establishment Labs Holdings, Inc. posted a negative return on equity (ROE) of -175.30, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.41, reflecting losses generated across the asset base. The company generates approximately 213,562.77 in revenue per employee across its workforce of 1,007.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.81 indicates how many times Establishment Labs Holdings, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Establishment Labs Holdings, Inc. recorded an income tax benefit of -7.51M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -41.55M and -34.04M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Establishment Labs Holdings, Inc.'s stock has gained approximately 32.20% over the past 52 weeks. The 50-day moving average sits at 59.33, while the 200-day moving average is 62.78.

Over the twelve months ended June 30, 2026, Establishment Labs Holdings, Inc. generated 215.16M in revenue and converted that into -34.04M in net income, yielding earnings per share of -1.14. EBITDA reached -7.08M, while operating income came in at -16.42M.

As of June 30, 2026, Establishment Labs Holdings, Inc. holds 62.28M in cash and equivalents against 230.79M in total debt, resulting in a net debt position of 166.78M. Total book value stands at 18.91M, with working capital of 160.33M providing operational flexibility.

Establishment Labs Holdings, Inc. produced -28.29M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -8.08M in capital expenditures, free cash flow totaled -36.37M - equivalent to -1.22 per share.

Over the twelve months ended June 30, 2026, Establishment Labs Holdings, Inc. posted a gross margin of 70.49, reflecting its pricing power and cost economics. The operating margin of -7.63 and net profit margin of -15.82 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -1.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.27, meaning Establishment Labs Holdings, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Establishment Labs Holdings, Inc. has an Altman Z-Score of 3.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.